Recommended Pages at healthinfoispower.wordpress.com
U.S. Food & Drug Administration Acts to Bolster Supply of Critically Needed Cancer Drugs Including Doxil « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “U.S. Food & Drug Administration Acts to Bolster Supply of Critically Needed Cancer Drugs Including Doxil « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on February 21, 2012 at 9:03 pm By:
Paul Cacciatore Patient Advocate
U.S. Food & Drug Administration Acts to Bolster Supply of Critically Needed Cancer Drugs Including Doxil http://t.co/ijbv3mpR
Can Iran Solve the Current U.S. Doxil/Caelyx Cancer Drug Shortage? « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “Can Iran Solve the Current U.S. Doxil/Caelyx Cancer Drug Shortage? « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on February 18, 2012 at 1:14 am By:
Paul Cacciatore Patient Advocate
Can Iran Solve the Current U.S. Doxil/Caelyx Cancer Drug Shortage? http://t.co/UDF0BrRA
An Attitude of Gratitude On Thanksgiving Day « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “An Attitude of Gratitude On Thanksgiving Day « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on November 24, 2011 at 7:51 pm By:
Paul Cacciatore Patient Advocate
An Attitude of Gratitude On Thanksgiving Day http://t.co/VxsJMAz0
U.S. President Barack Obama Proclaims September 2011 As National Ovarian Cancer Awareness Month — What Should You Know? « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “U.S. President Barack Obama Proclaims September 2011 As National Ovarian Cancer Awareness Month — What Should You Know? « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on September 1, 2011 at 11:03 pm By:
Paul Cacciatore Patient Advocate
U.S. President Barack Obama Proclaims September 2011 As National Ovarian Cancer Awareness Month -- What Should You K… http://t.co/I3p8pzb
NOCC to Host Annual “Walk To Break The Silence On Ovarian Cancer” in the Greater Washington, D.C. Area « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “NOCC to Host Annual “Walk To Break The Silence On Ovarian Cancer” in the Greater Washington, D.C. Area « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 31, 2011 at 11:16 pm By:
Paul Cacciatore Patient Advocate
NOCC to Host Annual "Walk To Break The Silence On Ovarian Cancer" in the Greater Washington, D.C. Area http://t.co/4wQ7GdQ
30-Day Mortality Associated With Primary Cytoreductive Surgery In Elderly Advanced Ovarian Cancer Patients Much Higher Than Previously Reported « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “30-Day Mortality Associated With Primary Cytoreductive Surgery In Elderly Advanced Ovarian Cancer Patients Much Higher Than Previously Reported « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 25, 2011 at 12:28 am By:
Paul Cacciatore Patient Advocate
30-Day Mortality Associated With Primary Cytoreductive Surgery In Elderly Advanced Ovarian Cancer Patients Much High… http://t.co/kUMeOZA
PARP Inhibitor Olaparib Has Activity in High-Grade Serous Ovarian Cancer Without Inherited BRCA1 or BRCA2 Gene Mutations « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “PARP Inhibitor Olaparib Has Activity in High-Grade Serous Ovarian Cancer Without Inherited BRCA1 or BRCA2 Gene Mutations « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 22, 2011 at 6:39 pm By:
Paul Cacciatore Patient Advocate
PARP Inhibitor Olaparib Has Activity in High-Grade Serous Ovarian Cancer Without Inherited BRCA1 or BRCA2 Gene Mutat… http://t.co/InbboZC
U.K. Researchers Launch Clinical Trial of Mercaptopurine (6-MP) In Women with Hereditary Breast and Ovarian Cancer « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “U.K. Researchers Launch Clinical Trial of Mercaptopurine (6-MP) In Women with Hereditary Breast and Ovarian Cancer « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 18, 2011 at 9:07 pm By:
Paul Cacciatore Patient Advocate
U.K. Researchers Launch Clinical Trial of Mercaptopurine (6-MP) In Women with Hereditary Breast and Ovarian Cancer http://t.co/YpbOctK
Mesothelin Antibodies Occur In Some Women With An Epidemiologic Risk For Ovarian Cancer. « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “Mesothelin Antibodies Occur In Some Women With An Epidemiologic Risk For Ovarian Cancer. « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 18, 2011 at 4:32 pm By:
Paul Cacciatore Patient Advocate
Mesothelin Antibodies Occur In Some Women With An Epidemiologic Risk For Ovarian Cancer. http://t.co/9htzMNm
Penn’s Genetically Modified T Cells Create Antitumor Effect In Mice With Folate Positive Ovarian Cancer; Clinical Trial Pending « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “Penn’s Genetically Modified T Cells Create Antitumor Effect In Mice With Folate Positive Ovarian Cancer; Clinical Trial Pending « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 17, 2011 at 10:50 pm By:
Paul Cacciatore Patient Advocate
Penn's Genetically Modified T Cells Create Antitumor Effect In Mice With Folate Positive Ovarian Cancer; Clinical Tr… http://t.co/jA48L7I
Advanced MRI Scan May Predict Chemotherapy Benefit In Late Stage Ovarian Cancer Patients After Just One Cycle « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “Advanced MRI Scan May Predict Chemotherapy Benefit In Late Stage Ovarian Cancer Patients After Just One Cycle « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 16, 2011 at 7:34 pm By:
Paul Cacciatore Patient Advocate
Advanced MRI Scan May Predict Chemotherapy Benefit In Late Stage Ovarian Cancer Patients After Just One Cycle http://t.co/Nl9anvU
Ovarian Cancer Awareness Through Social Media Technology — Are You Ready? « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “Ovarian Cancer Awareness Through Social Media Technology — Are You Ready? « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 14, 2011 at 11:08 pm By:
Paul Cacciatore Patient Advocate
Ovarian Cancer Awareness Through Social Media Technology -- Are You Ready? http://t.co/qj8fdqP
FDA Approves Clinical Protocol for Additional Phase 1 Study of TKM-PLK1 in Primary Liver Cancer or Liver Metastases « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “FDA Approves Clinical Protocol for Additional Phase 1 Study of TKM-PLK1 in Primary Liver Cancer or Liver Metastases « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 12, 2011 at 7:03 pm By:
Paul Cacciatore Patient Advocate
FDA Approves Clinical Protocol for Additional Phase 1 Study of TKM-PLK1 in Primary Liver Cancer or Liver Metastases http://t.co/W2fqQ4H
Inherited Mutations in RAD51D Gene Confer Susceptibility to Ovarian Cancer « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “Inherited Mutations in RAD51D Gene Confer Susceptibility to Ovarian Cancer « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 8, 2011 at 1:57 am By:
Paul Cacciatore Patient Advocate
Inherited Mutations in RAD51D Gene Confer Susceptibility to Ovarian Cancer http://wp.me/pcE2v-1Qo
In-Depth Review: The Cancer Genome Atlas Reports On Landmark Analysis of High-Grade Serous Ovarian Cancer « Libby's H*O*P*E*
healthinfoispower.wordpress.com — “In-Depth Review: The Cancer Genome Atlas Reports On Landmark Analysis of High-Grade Serous Ovarian Cancer « Libby's H*O*P*E*” View full resource at healthinfoispower.wordpress.com
Most Recently Shared on August 6, 2011 at 12:24 am By:
Paul Cacciatore Patient Advocate
In-Depth Review: The Cancer Genome Atlas Reports On Landmark Analysis of High-Grade Serous Ovarian Cancer http://wp.me/pcE2v-1Go
